United States Pharmaceuticals

Recro Pharma Inc (REPH)

Track

Stock chart
Ticker: REPH Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Reasons Bryan M.
1 purchase — total 25,000 USD
Buy 28 Aug 2023
Value US$678,212.63 | Price 471.65 | Shares 40,424
Buy 28 Aug 2023
Value US$3,857,688.64 | Price 310.62 | Shares 10,315
Buy 28 Aug 2023
Value US$50,000.00 | Price 0.40 | Shares 125,000
Buy 28 Aug 2023
Value US$25,000.00 | Price 0.40 | Shares 62,500
Buy 28 Aug 2023
Value US$10,111.01 | Price 0.46 | Shares 22,222
Buy 28 Aug 2023
Value US$15,000.00 | Price 0.40 | Shares 37,500
Buy 28 Aug 2023
Value US$25,000.00 | Price 0.40 | Shares 62,500
Buy 24 Aug 2023
Value US$56,000.00 | Price 0.40 | Shares 140,000
Buy 24 Aug 2023
Value US$2,500,000.00 | Price 0.40 | Shares 6,250,000
Proposed sale 22 May 2023
Value US$65,625.00 | Price 0.75 | Shares 87,500
Sale 27 Apr 2023
Value US$259,037.00 | Price 0.70 | Shares 370,000
Planned buy 15 Nov 2022
Value US$1,128.60 | Price 1.71 | Shares 660
Planned buy 17 Oct 2022
Value US$1,056.25 | Price 1.69 | Shares 625
Planned buy 15 Sep 2022
Value US$1,006.74 | Price 1.41 | Shares 714
Planned buy 15 Aug 2022
Value US$953.82 | Price 1.26 | Shares 757
Planned buy 15 Jul 2022
Value US$930.81 | Price 0.81 | Shares 1,150
Planned buy 15 Jun 2022
Value US$1,062.16 | Price 0.68 | Shares 1,562
Planned buy 16 May 2022
Value US$1,043.65 | Price 0.96 | Shares 1,086
Buy 19 Apr 2022
Value US$18,917.14 | Price 1.56 | Shares 12,100
Buy 18 Apr 2022
Value US$23,200.50 | Price 1.55 | Shares 15,000
Buy 18 Apr 2022
Value US$910.02 | Price 1.52 | Shares 600
Planned buy 18 Apr 2022
Value US$1,018.75 | Price 1.63 | Shares 625
Buy 18 Mar 2022
Value US$2,145.00 | Price 2.15 | Shares 1,000
Planned buy 15 Mar 2022
Value US$1,003.52 | Price 1.96 | Shares 512
Planned buy 15 Feb 2022
Value US$1,010.67 | Price 1.77 | Shares 571
Planned buy 18 Jan 2022
Value US$1,011.36 | Price 1.68 | Shares 602
Sale 21 Dec 2021
Value US$154,235.88 | Price 1.55 | Shares 99,398
Sale 16 Dec 2021
Value US$80,500.00 | Price 1.61 | Shares 50,000
Planned buy 15 Dec 2021
Value US$993.37 | Price 1.61 | Shares 617
Sale 15 Dec 2021
Value US$32,600.00 | Price 1.63 | Shares 20,000
Sale 14 Dec 2021
Value US$16,683.31 | Price 1.57 | Shares 10,602
Sale 13 Dec 2021
Value US$32,502.00 | Price 1.63 | Shares 20,000
Buy 17 Nov 2021
Value US$1,688.60 | Price 1.69 | Shares 1,000
Buy 12 Nov 2021
Value US$2,895.24 | Price 1.68 | Shares 1,725
Buy 12 Nov 2021
Value US$80.90 | Price 1.62 | Shares 50
Buy 12 Nov 2021
Value US$1,916.14 | Price 1.65 | Shares 1,162
Sale 11 Jun 2021
Value US$587,520.73 | Price 2.20 | Shares 266,667
Sale 11 Jun 2021
Value US$108,170.00 | Price 2.16 | Shares 50,000
Sale 10 Jun 2021
Value US$334,200.00 | Price 2.23 | Shares 150,000
Sale 22 Dec 2020
Value US$59,691.10 | Price 3.17 | Shares 18,830
Sale 22 Dec 2020
Value US$178,708.75 | Price 3.17 | Shares 56,375
Sale 18 Dec 2020
Value US$56,326.04 | Price 3.03 | Shares 18,587
Sale 18 Dec 2020
Value US$18,812.72 | Price 3.03 | Shares 6,208
Planned sale 17 Apr 2020
Value US$657,600.00 | Price 8.22 | Shares 80,000
Buy 17 May 2019
Value US$360,000.00 | Price 9.00 | Shares 40,000
Planned sale 13 May 2019
Value US$189,380.51 | Price 8.89 | Shares 21,306
Planned sale 13 May 2019
Value US$1,097,915.00 | Price 8.89 | Shares 123,500
Sale 24 May 2018
Value US$137,750.00 | Price 5.51 | Shares 25,000
Sale 24 May 2018
Value US$282,500.00 | Price 5.65 | Shares 50,000
Sale 24 May 2018
Value US$274,200.00 | Price 6.00 | Shares 45,700
Sale 24 May 2018
Value US$227,620.00 | Price 5.99 | Shares 38,000
Sale 24 May 2018
Value US$171,112.00 | Price 5.84 | Shares 29,300
Sale 13 Mar 2018
Value US$2,014,000.00 | Price 10.07 | Shares 200,000
Sale 9 Mar 2018
Value US$78,346.50 | Price 10.45 | Shares 7,500
Planned sale 4 Jan 2018
Value US$13,955.52 | Price 8.84 | Shares 1,579
Planned sale 4 Jan 2018
Value US$41,822.36 | Price 8.84 | Shares 4,732
Planned sale 3 Jan 2018
Value US$173,463.58 | Price 8.73 | Shares 19,863
Planned sale 3 Jan 2018
Value US$57,943.46 | Price 8.73 | Shares 6,635
Planned sale 2 Jan 2018
Value US$171,224.04 | Price 9.04 | Shares 18,947
Planned sale 2 Jan 2018
Value US$57,195.17 | Price 9.04 | Shares 6,329
Planned sale 29 Dec 2017
Value US$113,142.01 | Price 9.19 | Shares 12,305
Planned sale 29 Dec 2017
Value US$37,790.63 | Price 9.19 | Shares 4,110
Planned sale 28 Dec 2017
Value US$55,938.48 | Price 9.44 | Shares 5,926
Planned sale 28 Dec 2017
Value US$18,690.21 | Price 9.44 | Shares 1,980
Planned sale 27 Dec 2017
Value US$80,040.07 | Price 9.54 | Shares 8,391
Planned sale 27 Dec 2017
Value US$26,737.26 | Price 9.54 | Shares 2,803
Planned sale 26 Dec 2017
Value US$46,015.70 | Price 9.59 | Shares 4,798
Planned sale 26 Dec 2017
Value US$15,364.14 | Price 9.59 | Shares 1,602
Sale 21 Dec 2017
Value US$392,000.00 | Price 9.80 | Shares 40,000
Sale 21 Dec 2017
Value US$108,240.00 | Price 9.84 | Shares 11,000
Sale 20 Dec 2017
Value US$250,000.00 | Price 10.00 | Shares 25,000
Sale 13 Dec 2017
Value US$80,722.60 | Price 9.80 | Shares 8,237
Sale 13 Dec 2017
Value US$97,416.00 | Price 9.84 | Shares 9,900
Sale 12 Dec 2017
Value US$490,000.00 | Price 9.80 | Shares 50,000
Sale 12 Dec 2017
Value US$989.00 | Price 9.89 | Shares 100
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-28 2023-08-28 B Purchase
1.0
Reasons Bryan M.
Non-Executive Director
40,424 -46.1%
471.65
US$678,213 		40,424 -46.1% 471.65 US$678,213
2023-08-28 2023-08-28 B Purchase
Cant Elena
Non-Executive Director
10,315 -38.6%
310.62
US$3,857,689 		10,315 -38.6% 310.62 US$3,857,689
2023-08-28 2023-08-28 B Purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
35,852 +48.8%
58.78
US$3,670,003 		35,852 +48.8% 58.78 US$3,670,003
2023-08-28 2023-08-28 B Purchase
3.7
CHURCHILL WINSTON J
Non-Executive Director
62,500 +26.1%
0.40
US$25,000 		62,500 +26.1% 0.40 US$25,000
2023-08-28 2023-08-28 B Purchase
Ashton William
Non-Executive Director
22,222 +9.2%
0.46
US$10,111 		22,222 +9.2% 0.46 US$10,111
2023-08-28 2023-08-28 B Purchase
2.3
Miller James Charles
Non-Executive Director
37,500 +19.7%
0.40
US$15,000 		37,500 +19.7% 0.40 US$15,000
2023-08-28 2023-08-28 B Purchase
3.2
Weisman Wayne
Non-Executive Director
62,500 +25.4%
0.40
US$25,000 		62,500 +25.4% 0.40 US$25,000
2023-08-28 2023-08-24 B Purchase
3.3
AWM Investment Company, Inc.
Large shareholder
140,000 +1.4%
0.40
US$56,000 		140,000 +1.4% 0.40 US$56,000
2023-08-25 2023-08-24 B Purchase
Arens Mathew Paul
Non-Executive Director Large shareholder
6,250,000 +46.6%
0.40
US$2,500,000 		6,250,000 +46.6% 0.40 US$2,500,000
2023-05-22 2023-05-22 PrS Proposed sale
Berelowitz Michael

Director

Non-Executive Director
87,500
0.75
US$65,625 		87,500 0.75 US$65,625
2023-04-27 2023-04-27 S Sale
3.3
AWM Investment Company, Inc.
Large shareholder
370,000 -4.2%
0.70
US$259,037 		370,000 -4.2% 0.70 US$259,037
2022-11-16 2022-11-15 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
660 +0.1%
1.71
US$1,129 		660 +0.1% 1.71 US$1,129
2022-10-17 2022-10-17 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
625 +0.1%
1.69
US$1,056 		625 +0.1% 1.69 US$1,056
2022-09-16 2022-09-15 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
714 +0.1%
1.41
US$1,007 		714 +0.1% 1.41 US$1,007
2022-08-17 2022-08-15 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
757 +0.1%
1.26
US$954 		757 +0.1% 1.26 US$954
2022-07-18 2022-07-15 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
1,150 +0.2%
0.81
US$931 		1,150 +0.2% 0.81 US$931
2022-06-17 2022-06-15 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
1,562 +0.3%
0.68
US$1,062 		1,562 +0.3% 0.68 US$1,062
2022-05-18 2022-05-16 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
1,086 +0.2%
0.96
US$1,044 		1,086 +0.2% 0.96 US$1,044
2022-04-20 2022-04-19 B Purchase
3.3
AWM Investment Company, Inc.
Large shareholder
12,100 +0.2%
1.56
US$18,917 		12,100 +0.2% 1.56 US$18,917
2022-04-20 2022-04-18 B Purchase
3.3
AWM Investment Company, Inc.
Large shareholder
15,000 +0.3%
1.55
US$23,200 		15,000 +0.3% 1.55 US$23,200
2022-04-20 2022-04-18 B Purchase
3.3
AWM Investment Company, Inc.
Large shareholder
600 +0.0%
1.52
US$910 		600 +0.0% 1.52 US$910
2022-04-20 2022-04-18 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
625 +0.1%
1.63
US$1,019 		625 +0.1% 1.63 US$1,019
2022-03-22 2022-03-18 B Purchase
2.3
Miller James Charles
Non-Executive Director
1,000 +3.6%
2.15
US$2,145 		1,000 +3.6% 2.15 US$2,145
2022-03-17 2022-03-15 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
512 +0.1%
1.96
US$1,004 		512 +0.1% 1.96 US$1,004
2022-02-17 2022-02-15 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
571 +0.1%
1.77
US$1,011 		571 +0.1% 1.77 US$1,011
2022-01-19 2022-01-18 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
602 +0.4%
1.68
US$1,011 		602 +0.4% 1.68 US$1,011
2021-12-23 2021-12-21 S Sale
3.3
AWM Investment Company, Inc.
Large shareholder
99,398 -1.9%
1.55
US$154,236 		99,398 -1.9% 1.55 US$154,236
2021-12-20 2021-12-16 S Sale
3.3
AWM Investment Company, Inc.
Large shareholder
50,000 -1.0%
1.61
US$80,500 		50,000 -1.0% 1.61 US$80,500
2021-12-17 2021-12-15 PP Planned purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
617 +0.4%
1.61
US$993 		617 +0.4% 1.61 US$993
2021-12-15 2021-12-15 S Sale
3.3
AWM Investment Company, Inc.
Large shareholder
20,000 -0.4%
1.63
US$32,600 		20,000 -0.4% 1.63 US$32,600
2021-12-15 2021-12-14 S Sale
3.3
AWM Investment Company, Inc.
Large shareholder
10,602 -0.2%
1.57
US$16,683 		10,602 -0.2% 1.57 US$16,683
2021-12-15 2021-12-13 S Sale
3.3
AWM Investment Company, Inc.
Large shareholder
20,000 -0.4%
1.63
US$32,502 		20,000 -0.4% 1.63 US$32,502
2021-11-19 2021-11-17 B Purchase
2.3
Miller James Charles
Non-Executive Director
1,000 +3.7%
1.69
US$1,689 		1,000 +3.7% 1.69 US$1,689
2021-11-16 2021-11-12 B Purchase
2.2
ENLOE J DAVID JR

Chief Executive Officer

Executive Director
1,725 +1.1%
1.68
US$2,895 		1,725 +1.1% 1.68 US$2,895
2021-11-16 2021-11-12 B Purchase
2.3
Lake Ryan David

Chief Financial Officer

Officer
50 +0.0%
1.62
US$81 		50 +0.0% 1.62 US$81
2021-11-16 2021-11-12 B Purchase
2.3
Lake Ryan David

Chief Financial Officer

Officer
1,162 +0.3%
1.65
US$1,916 		1,162 +0.3% 1.65 US$1,916
2021-06-14 2021-06-11 S Sale
3.3
AWM Investment Company, Inc.
Large shareholder
266,667 -5.7%
2.20
US$587,521 		266,667 -5.7% 2.20 US$587,521
2021-06-14 2021-06-11 S Sale
3.3
AWM Investment Company, Inc.
Large shareholder
50,000 -1.1%
2.16
US$108,170 		50,000 -1.1% 2.16 US$108,170
2021-06-14 2021-06-10 S Sale
3.3
AWM Investment Company, Inc.
Large shareholder
150,000 -3.1%
2.23
US$334,200 		150,000 -3.1% 2.23 US$334,200
2020-12-28 2020-12-22 S Sale
1.8
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
18,830 -2.6%
3.17
US$59,691 		18,830 -2.6% 3.17 US$59,691
2020-12-28 2020-12-22 S Sale
1.8
SCP Vitalife Partners II LP
Large shareholder
56,375 -2.6%
3.17
US$178,709 		56,375 -2.6% 3.17 US$178,709
2020-12-22 2020-12-18 S Sale
1.8
SCP Vitalife Partners II LP
Large shareholder
18,587 -0.9%
3.03
US$56,326 		18,587 -0.9% 3.03 US$56,326
2020-12-22 2020-12-18 S Sale
1.8
SCP Vitalife Partners (Israel) II, L.P.
Large shareholder
6,208 -0.9%
3.03
US$18,813 		6,208 -0.9% 3.03 US$18,813
2020-04-20 2020-04-17 PlS Planned sale
2.5
HENWOOD GERALDINE

President and CEO

Executive Director
80,000 -33.2%
8.22
US$657,600 		80,000 -33.2% 8.22 US$657,600
2019-05-21 2019-05-17 B Purchase
3.0
Ajdler Arnaud
Non-Executive Director
40,000 +3.8%
9.00
US$360,000 		40,000 +3.8% 9.00 US$360,000
2019-05-15 2019-05-13 PlS Planned sale
2.5
HENWOOD GERALDINE

President and CEO

Executive Director
21,306 -9.7%
8.89
US$189,381 		21,306 -9.7% 8.89 US$189,381
2019-05-15 2019-05-13 PlS Planned sale
2.5
HENWOOD GERALDINE

President and CEO

Executive Director
123,500 -36.0%
8.89
US$1,097,915 		123,500 -36.0% 8.89 US$1,097,915
2018-05-24 2018-05-24 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -1.2%
5.51
US$137,750 		25,000 -1.2% 5.51 US$137,750
2018-05-24 2018-05-24 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -2.4%
5.65
US$282,500 		50,000 -2.4% 5.65 US$282,500
2018-05-24 2018-05-24 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
45,700 -2.1%
6.00
US$274,200 		45,700 -2.1% 6.00 US$274,200
2018-05-24 2018-05-24 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
38,000 -1.7%
5.99
US$227,620 		38,000 -1.7% 5.99 US$227,620
2018-05-24 2018-05-24 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
29,300 -1.3%
5.84
US$171,112 		29,300 -1.3% 5.84 US$171,112
2018-03-15 2018-03-13 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
200,000 -8.2%
10.07
US$2,014,000 		200,000 -8.2% 10.07 US$2,014,000
2018-03-13 2018-03-09 S Sale Berelowitz Michael
7,500 -100.0%
10.45
US$78,346 		7,500 -100.0% 10.45 US$78,346
2018-01-08 2018-01-04 PlS Planned sale SCP Vitalife Partners (Israel) II, L.P. Large shareholder
1,579 -0.2%
8.84
US$13,956 		1,579 -0.2% 8.84 US$13,956
2018-01-08 2018-01-04 PlS Planned sale SCP Vitalife Partners II LP Large shareholder
4,732 -0.2%
8.84
US$41,822 		4,732 -0.2% 8.84 US$41,822
2018-01-04 2018-01-03 PlS Planned sale SCP Vitalife Partners II LP Large shareholder
19,863 -0.9%
8.73
US$173,464 		19,863 -0.9% 8.73 US$173,464
2018-01-04 2018-01-03 PlS Planned sale SCP Vitalife Partners (Israel) II, L.P. Large shareholder
6,635 -0.9%
8.73
US$57,943 		6,635 -0.9% 8.73 US$57,943
2018-01-04 2018-01-02 PlS Planned sale SCP Vitalife Partners II LP Large shareholder
18,947 -0.9%
9.04
US$171,224 		18,947 -0.9% 9.04 US$171,224
2018-01-04 2018-01-02 PlS Planned sale SCP Vitalife Partners (Israel) II, L.P. Large shareholder
6,329 -0.9%
9.04
US$57,195 		6,329 -0.9% 9.04 US$57,195
2018-01-02 2017-12-29 PlS Planned sale SCP Vitalife Partners II LP Large shareholder
12,305 -0.6%
9.19
US$113,142 		12,305 -0.6% 9.19 US$113,142
2018-01-02 2017-12-29 PlS Planned sale SCP Vitalife Partners (Israel) II, L.P. Large shareholder
4,110 -0.6%
9.19
US$37,791 		4,110 -0.6% 9.19 US$37,791
2018-01-02 2017-12-28 PlS Planned sale SCP Vitalife Partners II LP Large shareholder
5,926 -0.3%
9.44
US$55,938 		5,926 -0.3% 9.44 US$55,938
2018-01-02 2017-12-28 PlS Planned sale SCP Vitalife Partners (Israel) II, L.P. Large shareholder
1,980 -0.3%
9.44
US$18,690 		1,980 -0.3% 9.44 US$18,690
2017-12-28 2017-12-27 PlS Planned sale SCP Vitalife Partners II LP Large shareholder
8,391 -0.4%
9.54
US$80,040 		8,391 -0.4% 9.54 US$80,040
2017-12-28 2017-12-27 PlS Planned sale SCP Vitalife Partners (Israel) II, L.P. Large shareholder
2,803 -0.4%
9.54
US$26,737 		2,803 -0.4% 9.54 US$26,737
2017-12-28 2017-12-26 PlS Planned sale SCP Vitalife Partners II LP Large shareholder
4,798 -0.2%
9.59
US$46,016 		4,798 -0.2% 9.59 US$46,016
2017-12-28 2017-12-26 PlS Planned sale SCP Vitalife Partners (Israel) II, L.P. Large shareholder
1,602 -0.2%
9.59
US$15,364 		1,602 -0.2% 9.59 US$15,364
2017-12-22 2017-12-21 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
40,000 -1.6%
9.80
US$392,000 		40,000 -1.6% 9.80 US$392,000
2017-12-22 2017-12-21 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
11,000 -0.4%
9.84
US$108,240 		11,000 -0.4% 9.84 US$108,240
2017-12-22 2017-12-20 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
25,000 -1.0%
10.00
US$250,000 		25,000 -1.0% 10.00 US$250,000
2017-12-14 2017-12-13 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
8,237 -0.3%
9.80
US$80,723 		8,237 -0.3% 9.80 US$80,723
2017-12-14 2017-12-13 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
9,900 -0.4%
9.84
US$97,416 		9,900 -0.4% 9.84 US$97,416
2017-12-14 2017-12-12 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
50,000 -1.9%
9.80
US$490,000 		50,000 -1.9% 9.80 US$490,000
2017-12-14 2017-12-12 S Sale Broadfin Healthcare Master Fund Ltd Large shareholder
100 -0.0%
9.89
US$989 		100 -0.0% 9.89 US$989
Explore more

More insider trading research around Recro Pharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America